• Study on the Effectiveness and Safety of AC102 Injection vs. Oral Prednisolone for Patients with Sudden Hearing Loss

    Not recruiting

    2 1 1
    Investigated Diseases:
    Austria Czechia Germany The Netherlands Poland
  • Study Comparing Trastuzumab Deruxtecan and Trastuzumab Emtansine for Patients with High-Risk HER2-Positive Breast Cancer with Residual Disease After Initial Treatment

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Belgium Czechia Denmark France Germany Greece +7
  • Study on Alpelisib and Fulvestrant for Men and Postmenopausal Women with Advanced HR-positive, HER2-negative Breast Cancer with PIK3CA Mutation

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Bulgaria Czechia Denmark Finland France +10
  • Study on Bevacizumab for Patients with Newly Diagnosed IDH Wild-Type, MGMT Unmethylated Glioblastoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany
  • Study on the Effects of Sapablursen for Patients with Phlebotomy Dependent Polycythemia Vera

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Poland
  • Study on the Effectiveness and Safety of Guselkumab for Patients with Moderate to Severe Ulcerative Colitis

    Not recruiting

    4 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Bulgaria Czechia France Germany Hungary +7
  • Study of enzalutamide alone versus enzalutamide with radium-223 combination in patients with bone metastatic castration-resistant prostate cancer with mild or no symptoms

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Belgium Denmark France Ireland Italy Norway +2
  • Study on Apixaban for Patients with Intrahepatic Non-Cirrhotic Portal Hypertension

    Not recruiting

    3 1 1
    Investigated Drugs:
    France
  • Study on Ramucirumab and Paclitaxel for Older Patients with Advanced Stomach Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Study on Niraparib’s Effects and Safety in Patients with High-Grade Serous Ovarian Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    France

powered by